Chandola Stuti, Soni Abhishek, Banerjee Soham, Bhattacharjee Hemanga K, Sharma Raju, Phulia Ankita, Pathy Sushmita, Das Chandan J
All India Institute of Medical Sciences, New Delhi, India.
Maulana Azad Medical College, New Delhi, India.
Abdom Radiol (NY). 2025 Jun;50(6):2339-2350. doi: 10.1007/s00261-024-04689-8. Epub 2024 Nov 25.
To evaluate the performance of intravoxel incoherent motion and diffusion kurtosis imaging (IVIM- DKI) in response assessment of rectosigmoid carcinoma to chemo-radiotherapy (CRT) and compare with 18-FDG PET/CT parameters.
A total of 30 patients of recto-sigmoid cancer on CRT underwent baseline staging and follow-up with IVIM - DKI. Out of this cohort, 20 patients underwent 18-FDG PET/CT. IVIM- DKI MRI and PET/CT parameters were noted from both pre and post-chemoradiotherapy (done at 6 weeks after completion) scans. Quantitative IVIM-DKI parameters, viz. apparent (ADC) and molecular (D) diffusion coefficient, perfusion coefficient (f), and kurtosis (K) were measured from non-necrotic areas and semi-quantitative PET parameters including SUV max, SUV ratio, metabolic tumor volume (MTV), total lesion glycolysis (TLG) were also measured. All these parameters correlated with the patient's response keeping RECIST 1.1 criteria as reference standard.
A statistically significant increase in D and ADC with a significant decline in K was noted after therapy in the entire cohort. These changes were observed in both responders as well as non-responders. No significant differences were observed in the percentage changes of these parameters post therapy amongst both groups. Among 20 patients with follow-up PET/CT imaging, a significant decline in all parameters of primary lesion was seen post-therapy. Responders (n = 12) showed a significant decline in MTV and TLG from baseline after therapy, whereas non-responders did not show any such decline. Change in TLG (ɗ TLG), followed by ɗ MTV had the strongest correlation with a positive response. A ɗ TLG value of ≥ 54.19 carried a 79% sensitivity and 83% specificity in differentiating responders from non responders.
18-FDG PET/CT is a more accurate single modality for assessing both response and tumor burden post therapy, while ADC and D from IVIM MRI are useful adjuncts to response assessment.
评估体素内不相干运动和扩散峰度成像(IVIM-DKI)在直肠乙状结肠癌放化疗(CRT)疗效评估中的表现,并与18-FDG PET/CT参数进行比较。
共有30例接受CRT的直肠乙状结肠癌患者接受了IVIM-DKI基线分期及随访。在该队列中,20例患者接受了18-FDG PET/CT检查。记录放化疗前(完成后6周进行)和放化疗后扫描的IVIM-DKI MRI和PET/CT参数。从非坏死区域测量定量IVIM-DKI参数,即表观扩散系数(ADC)和分子扩散系数(D)、灌注系数(f)和峰度(K),还测量了包括SUV最大值、SUV比值、代谢肿瘤体积(MTV)、总病变糖酵解(TLG)在内的半定量PET参数。所有这些参数均以RECIST 1.1标准作为参考标准与患者的疗效相关联。
整个队列在治疗后观察到D和ADC有统计学意义的增加,K有显著下降。在反应者和无反应者中均观察到这些变化。两组治疗后这些参数的百分比变化无显著差异。在20例接受随访PET/CT成像的患者中,治疗后原发灶的所有参数均有显著下降。反应者(n = 12)治疗后MTV和TLG较基线有显著下降,而无反应者未显示任何此类下降。TLG的变化(ΔTLG),其次是ΔMTV与阳性反应的相关性最强。ΔTLG值≥54.19在区分反应者与无反应者时的敏感性为79%,特异性为83%。
18-FDG PET/CT是评估治疗后疗效和肿瘤负荷更准确的单一模式,而IVIM MRI的ADC和D是疗效评估的有用辅助指标。